Progesterone levels and early pregnancy bleeding in breastfeeding women
Part of Women’s health & pregnancy clinical trials.
This study looks at whether progesterone levels in early pregnancy are different in women who get pregnant while breastfeeding. It may help understand why some women experience bleeding or spotting during early pregnancy when breastfeeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 50 years old
- Be pregnant and currently breastfeeding (or got pregnant while breastfeeding)
- Be in the first 3 months of pregnancy
- Be pregnant with only one baby
- Not have taken progesterone supplements before your first blood test
- Receive prenatal care at a participating hospital
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies outcomes for pregnant women who have genital bleeding after 18 weeks. It aims to understand how bleeding affects both mother and baby.
This study compares two ways of giving progesterone to postmenopausal women. It aims to see how the body absorbs each form, which may help guide future treatment options.
This study looks at how progesterone levels change in the early part of the luteal phase (after ovulation) when ovulation is triggered by an hCG injection in a natural cycle. It may help women undergoing routine ovulation induction understand how their body responds.
This trial tests if taking progesterone early in pregnancy can help prevent preeclampsia, a condition of high blood pressure. You may qualify if you are over 18, speak English, and are less than 12 weeks pregnant.
This study looks at whether the level of progesterone, a hormone that helps prepare the uterus for pregnancy, on the day of embryo transfer affects the chance of a successful pregnancy in women using frozen embryos. It may help doctors understand if adjusting progesterone could improve outcomes.
This study tests two treatments—progesterone (a hormone) and a blood thinner (low molecular weight heparin)—to see if they help women who have had repeated miscarriages carry a pregnancy to term. If you join, you may receive one or both treatments during your pregnancy.
Hear when a new Threatened Abortion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.